Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$8.85
-3.5%
$9.11
$0.06
$14.93
$6.76M0.98566,370 shs3,647 shs
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
$10.30
$9.72
$18.20
$450MN/A2.07 million shs40,482 shs
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
$1.34
+25.9%
$0.69
$0.27
$1.31
$61.09M0.442.54 million shs2.71 million shs
Shoal Games Ltd stock logo
SGW
Shoal Games
C$0.50
+42.9%
C$0.50
C$0.35
C$0.67
C$65.56MN/A3,250 shs500 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.00%-0.78%-3.17%-3.17%-76.59%
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
0.00%0.00%0.00%0.00%0.00%
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
0.00%+20.27%+98.54%+230.28%+33.50%
Shoal Games Ltd stock logo
SGW
Shoal Games
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
1.6553 of 5 stars
3.50.00.00.03.00.00.0
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
1.7329 of 5 stars
3.53.00.00.00.60.00.6
Shoal Games Ltd stock logo
SGW
Shoal Games
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
3.00
Buy$275.003,007.34% Upside
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
0.00
N/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
3.00
Buy$4.00199.63% Upside
Shoal Games Ltd stock logo
SGW
Shoal Games
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SGW, AIM, IPA, and FRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/11/2025
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$5.00 ➝ $5.00
(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$146K46.31N/AN/A$0.20 per share44.25
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/AN/AN/AN/A$0.56 per shareN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
$18.16M3.36N/AN/A$0.93 per share1.44
Shoal Games Ltd stock logo
SGW
Shoal Games
C$106.98K612.86C$0.01 per share100.00C$0.01 per share55.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$28.96M-$24.00N/AN/AN/A-12,594.21%-421.73%-147.54%N/A
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
-$7.92MN/A0.00N/AN/AN/AN/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
-$20.13M-$1.16N/AN/AN/A-190.76%-88.87%-49.26%8/4/2025 (Estimated)
Shoal Games Ltd stock logo
SGW
Shoal Games
N/A-C$0.04N/AN/AN/AN/AN/AN/A

Latest SGW, AIM, IPA, and FRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025N/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
-$0.02N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/AN/AN/AN/AN/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
N/AN/AN/AN/AN/A
Shoal Games Ltd stock logo
SGW
Shoal Games
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.05
0.75
0.75
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/A
0.37
0.37
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
0.45
2.32
2.11
Shoal Games Ltd stock logo
SGW
Shoal Games
N/A
8.30
7.20

Institutional Ownership

CompanyInstitutional Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
12.02%
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
6.70%
Shoal Games Ltd stock logo
SGW
Shoal Games
N/A

Insider Ownership

CompanyInsider Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.02%
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/A
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
6.83%
Shoal Games Ltd stock logo
SGW
Shoal Games
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
20764,00068.74 millionNot Optionable
Forest Road Acquisition Corp. stock logo
FRX
Forest Road Acquisition
N/A37.50 millionN/ANot Optionable
ImmunoPrecise Antibodies Ltd. stock logo
IPA
ImmunoPrecise Antibodies
8045.76 million42.64 millionNot Optionable
Shoal Games Ltd stock logo
SGW
Shoal Games
40131.13 millionN/ANot Optionable

Recent News About These Companies

19/19-21 Shoal Bay Road, Shoal Bay NSW 2315
Filipino sailors hold the line at flashpoint Sabina Shoal
The Best Strategy Board Games
The best skateboard games 2024
How to uninstall Steam games (and reinstall them later)
The Best Card Games
Best Xbox kids games 2023
Shoal Creek Elementary School
The best PS4 games in 2023
Chinese, Philippine Vessels Collide Near Contested Shoal

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSE:AIM

$8.85 -0.32 (-3.49%)
Closing price 07/3/2025 03:30 PM Eastern
Extended Trading
$8.95 +0.10 (+1.13%)
As of 07/3/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Forest Road Acquisition stock logo

Forest Road Acquisition NYSE:FRX

Forest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.

ImmunoPrecise Antibodies stock logo

ImmunoPrecise Antibodies NASDAQ:IPA

$1.34 +0.28 (+25.94%)
Closing price 07/3/2025 03:58 PM Eastern
Extended Trading
$1.34 0.00 (0.00%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; and peptide production for subsequent antibody discovery campaign. In addition, it provides B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. The company also offers phage display, a custom immune libraries from multiple species; and CAR development, an adaptable antibody which allows the inclusion of functional data early in the screening funnel. Further, it provides silico developability, a profiling toolset for antibody lead candidates; and vitro analytical tools for the study of various critical quality attributes. Additionally, the company offers LucinaTech, an antibody humanization to identify essential framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; and antibody chimerization for cloning and production of variable antibody domain. It also provides Eurofins preclinical services; hybrid service model, a service model designed to reduce time and risk with custom technologies and applications; and breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts. The company was incorporated in 1983 and is headquartered in Victoria, Canada.

Shoal Games stock logo

Shoal Games CVE:SGW

C$0.50 +0.15 (+42.86%)
As of 04/8/2019

Shoal Games Ltd. develops and sells consumer mobile software products and games in Anguilla and internationally. It focuses on the development and marketing of a platform of interactive games for families and children. The company's products include Rooplay, a platform of educational and entertainment games; Garfield's Bingo, a bingo game; and Trophy Bingo, live through mobile platforms. The company was formerly known as Bingo.com, Ltd. and changed its name to Shoal Games Ltd. in January 2015. Shoal Games Ltd. was founded in 1987 and is based in The Valley, Anguilla.